The stock of Dynavax Technologies Corp (NASDAQ:DVAX) last traded at $13.64, down -1.87% from the previous session.
DVAX stock price is now 3.51% away from the 50-day moving average and 13.74% away from the 200-day moving average. The market capitalization of the company currently stands at $1.69B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $15 to $12, Goldman Downgraded its rating from Neutral to Sell for Dynavax Technologies Corp (NASDAQ: DVAX). On February 01, 2024, Goldman recently initiated its ‘Neutral’ rating on the stock quoting a target price of $20, while ‘JMP Securities’ rates the stock as ‘Mkt Outperform’
In other news, DAVID NOVACK, Officer bought 14,020 shares of the company’s stock on Mar 18 ’25. The stock was bought for $190,386 at an average price of $13.58. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 07 ’25, President & COO Novack David F sold 32,764 shares of the business’s stock. A total of $471,474 was realized by selling the stock at an average price of $14.39. This leaves the insider owning 22,098 shares of the company worth $0.3 million. A total of 4.67% of the company’s stock is owned by insiders.
During the past 12 months, Dynavax Technologies Corp has had a low of $9.74 and a high of $14.63. As of last week, the company has a debt-to-equity ratio of 0.43, a current ratio of 10.80, and a quick ratio of 9.91. According to the stock market information, the enterprise value for the company is $1232909056, which is based on a 78.08 price-to-earnings ratio, a 1.47 price-to-earnings-growth ratio, and a beta of 1.23. The fifty day moving average price for DVAX is $13.178 and a two-hundred day moving average price translates $11.99245 for the stock.
The latest earnings results from Dynavax Technologies Corp (NASDAQ: DVAX) was released for 2024-12-31. The net profit margin was 9.85% and return on equity was 4.48% for DVAX. The company reported revenue of $72.03 million for the quarter, compared to $55.6 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 29.56 percent.
